[1] |
Pan Meimin, Li Wenjuan, Jiang Fangqing, et al..
Changes of serum IL-17A,fibroblast growth factor and IL-7 levels in patients with hepatitis C virus infection
[J]. Journal of Practical Hepatology, 2019, 22(6): 840-843.
|
[2] |
Yang Caiyong, Chen Na, Li Kui, et al..
Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis
[J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
|
[3] |
Deng Haohui, Li Xiaoqiang, Gao Hongbo, et al.
Comparison of HCV genotypes in patients with HIV/HCV co-infection and HCV mono-infection in Guangzhou
[J]. Journal of Practical Hepatology, 2019, 22(5): 656-659.
|
[4] |
Liu Li,Li Junyi,Du Yingrong.
Efficacy and safety of sofosbuvir/daclatasvir in the treatment of patients with chronic hepatitis C and hepatitis C cirrhosis:An real-world study
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 361-364.
|
[5] |
Jiang Yi, Liu Bing.
Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
|
[6] |
Wu Jing, Dong Baoji, Wu Chao.
Comparison of PD-1 receptor on peripheral blood follicular helper T lymphocyte surface in chronic hepatitis C patients with low and high serum viral loads
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 192-195.
|
[7] |
Wu Yaping, Zhou Bingqing, Jiang Peili.
Risk factors of severe hepatic fibrosis in patients with chronic hepatitis C with previous paid blood donation
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 196-199.
|
[8] |
Yang Zhenjie, Li Hongtao, Wang Jian, Li Xia, Chen Yuan.
Efficacy of combination of pegylated interferon-α-2a and ribavirin in treatment of patients with compensated hepatitis C cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 232-235.
|
[9] |
Hou Chunyang, Ma Yumei, Li Fangzhi..
Clinical efficacy of peg-IFNα and ribavirin combination in treating patients with chronic hepatitis C and genotype one and six infection
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 53-56.
|
[10] |
Zhao Peng, Wang Lei..
Comparison of therapeutic efficacy of pegylated interferon-α in treatment of patients with different hepatitis C viral genotype infection
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 57-60.
|
[11] |
Xu Xi, Dang Yinli, Wu Shuo..
Construction and expression of recombinant eukaryotic expression vector of HCV infection related interferon λ4
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 833-836.
|
[12] |
Ji Xiaoqin, Gong Jian..
Clinical features and antiviral treatment of elderly patients with chronic hepatitis C
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 995-998.
|
[13] |
Zhou Sisi, Shen Youxiu, Li Juan, et al..
Changes of peripheral blood Th17 and Treg cells and their related serum cytokines in patients with chronic hepatitis C and liver cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 689-692.
|
[14] |
Cao Fenghua, Jing Jisheng, Zhao Wei, et al..
Clinical efficacy and safety of large dose of domestic interferon-α2b and ribavirin in the treatment of patients with chronic hepatitis C
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 729-732.
|
[15] |
Jiang Hongda, Zhou Haizhou..
Serum autoantibodies in patients with hepatitis C
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 817-820.
|